Mohammad Karbassi, MD - Medicare Ophthalmology in Longmont, CO

Mohammad Karbassi, MD is a medicare enrolled "Ophthalmology" physician in Longmont, Colorado. He went to George Washington University School Of Medicine and graduated in 1988 and has 36 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Front Range Eye Physicians Pc and his current practice location is 205 S Main St, Suite D, Longmont, Colorado. You can reach out to his office (for appointments etc.) via phone at (303) 772-3611.

Mohammad Karbassi is licensed to practice in Colorado (license number 44707) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1083659338.

Contact Information

Mohammad Karbassi, MD
205 S Main St, Suite D,
Longmont, CO 80501-1716
(303) 772-3611
(303) 772-3609



Physician's Profile

Full NameMohammad Karbassi
GenderMale
SpecialityOphthalmology
Experience36 Years
Location205 S Main St, Longmont, Colorado
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Mohammad Karbassi attended and graduated from George Washington University School Of Medicine in 1988
  NPI Data:
  • NPI Number: 1083659338
  • Provider Enumeration Date: 06/19/2006
  • Last Update Date: 01/18/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 3971506379
  • Enrollment ID: I20060823000614

Medical Identifiers

Medical identifiers for Mohammad Karbassi such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1083659338NPI-NPPES
KAM4707OtherANTHEM BS
931468OtherCOEYE SPECIALISTS
5476659OtherAETNA
841353910OtherCOTOTAL LONG TERM CARE
SS#841353910OtherVSP
44707OtherCOMEDICAL LICENSE
841353910002OtherCOROCKY MOUNTAIN HMO

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207W00000XOphthalmology 44707 (Colorado)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Front Range Eye Physicians Pc25676152482

News Archive

Patients receiving cancer treatment may experience skin, hair, nail problems

A cancer diagnosis and subsequent treatment, which commonly includes chemotherapy or radiation, can be taxing physically and emotionally on any patient. If that is not enough, dermatologists are cautioning patients receiving cancer treatment and cancer survivors that they may experience a host of skin, hair or nail problems as a direct result of their therapy that may require additional treatment by a dermatologist.

Simple molecular kit to reprogram any cell of the body into another

In an effort to sidestep the ethical dilemma involved in using human embryonic stem cells to treat diseases, scientists are developing non-controversial alternatives: In particular, they are looking for drug-like chemical compounds that can transform adult skin cells into the stem cells now obtained from human embryos. That's the topic of a fascinating article in Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

Reconciliation update: Some Dems, GOP and industry groups wary health bill strategy

The Los Angeles Times: "Obama's signature ability to inspire fellow Democrats and Pelosi's well-honed ability to read their parochial needs will be tested as they tackle the job of finding the last stubborn votes for the healthcare bill. ... "Under the Democrats' strategy, the House would pass the Senate's version of the bill. Then both chambers would approve changes under the budget reconciliation process, which could pass the Senate with a simple 51-vote majority. Democrats hope to finish by the end of the month" (Hook and Levey, 3/8).

AngioDynamics commences treatment in NanoKnife IRE System pilot study for HCC

AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnifeĀ® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mohammad Karbassi allows following entities to bill medicare on his behalf.
Entity NameFront Range Eye Physicians Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1881961316
PECOS PAC ID: 2567615248
Enrollment ID: O20130107000131

News Archive

Patients receiving cancer treatment may experience skin, hair, nail problems

A cancer diagnosis and subsequent treatment, which commonly includes chemotherapy or radiation, can be taxing physically and emotionally on any patient. If that is not enough, dermatologists are cautioning patients receiving cancer treatment and cancer survivors that they may experience a host of skin, hair or nail problems as a direct result of their therapy that may require additional treatment by a dermatologist.

Simple molecular kit to reprogram any cell of the body into another

In an effort to sidestep the ethical dilemma involved in using human embryonic stem cells to treat diseases, scientists are developing non-controversial alternatives: In particular, they are looking for drug-like chemical compounds that can transform adult skin cells into the stem cells now obtained from human embryos. That's the topic of a fascinating article in Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

Reconciliation update: Some Dems, GOP and industry groups wary health bill strategy

The Los Angeles Times: "Obama's signature ability to inspire fellow Democrats and Pelosi's well-honed ability to read their parochial needs will be tested as they tackle the job of finding the last stubborn votes for the healthcare bill. ... "Under the Democrats' strategy, the House would pass the Senate's version of the bill. Then both chambers would approve changes under the budget reconciliation process, which could pass the Senate with a simple 51-vote majority. Democrats hope to finish by the end of the month" (Hook and Levey, 3/8).

AngioDynamics commences treatment in NanoKnife IRE System pilot study for HCC

AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnifeĀ® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mohammad Karbassi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mohammad Karbassi, MD
205 S Main St, Suite D,
Longmont, CO 80501-1716

Ph: (303) 772-3611
Mohammad Karbassi, MD
205 S Main St, Suite D,
Longmont, CO 80501-1716

Ph: (303) 772-3611

News Archive

Patients receiving cancer treatment may experience skin, hair, nail problems

A cancer diagnosis and subsequent treatment, which commonly includes chemotherapy or radiation, can be taxing physically and emotionally on any patient. If that is not enough, dermatologists are cautioning patients receiving cancer treatment and cancer survivors that they may experience a host of skin, hair or nail problems as a direct result of their therapy that may require additional treatment by a dermatologist.

Simple molecular kit to reprogram any cell of the body into another

In an effort to sidestep the ethical dilemma involved in using human embryonic stem cells to treat diseases, scientists are developing non-controversial alternatives: In particular, they are looking for drug-like chemical compounds that can transform adult skin cells into the stem cells now obtained from human embryos. That's the topic of a fascinating article in Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

Reconciliation update: Some Dems, GOP and industry groups wary health bill strategy

The Los Angeles Times: "Obama's signature ability to inspire fellow Democrats and Pelosi's well-honed ability to read their parochial needs will be tested as they tackle the job of finding the last stubborn votes for the healthcare bill. ... "Under the Democrats' strategy, the House would pass the Senate's version of the bill. Then both chambers would approve changes under the budget reconciliation process, which could pass the Senate with a simple 51-vote majority. Democrats hope to finish by the end of the month" (Hook and Levey, 3/8).

AngioDynamics commences treatment in NanoKnife IRE System pilot study for HCC

AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnifeĀ® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.

Read more News

› Verified 8 days ago


Ophthalmology Doctors in Longmont, CO

William L Benedict, M.D.
Ophthalmology
Medicare: Medicare Enrolled
Practice Location: 1400 Dry Creek Dr, Longmont, CO 80503
Phone: 303-772-3300    Fax: 303-682-3380
Aimee Morris Verner, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 1400 Dry Creek Dr, Longmont, CO 80503
Phone: 303-772-3300    Fax: 303-682-3380
Micah W Rothstein, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 1400 Dry Creek Dr, Longmont, CO 80503
Phone: 303-772-3300    Fax: 303-682-3380
Irene Olijnyk, M.D.
Ophthalmology
Medicare: Medicare Enrolled
Practice Location: 1400 Dry Creek Dr, Longmont, CO 80503
Phone: 303-772-3300    Fax: 303-682-3380
Dr. Dale S. Johnson, M.D.
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 1319 Vivian St, Longmont, CO 80501
Phone: 303-772-3611    Fax: 303-772-3609
Diane Towako Siegel, MD
Ophthalmology
Medicare: May Accept Medicare Assignments
Practice Location: 1400 Dry Creek Dr, Longmont, CO 80503
Phone: 303-772-3300    Fax: 303-682-3380

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.